Arvind Kush
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ David McIntyre, attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Arvind Kush:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | Director | Common Stock | 145,000 | $198,650 | $1.37 | 21 Oct 2024 | Direct |
| RayzeBio, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 0 | $0 | $62.50 | 26 Feb 2024 | Direct |
| Inhibikase Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 108,176 | 30 Jun 2025 | Direct | ||
| RayzeBio, Inc. | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 0 | 26 Feb 2024 | Direct |
Insider Reports Filed by Arvind Kush
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | 30 Jun 2025 | 1 | $0 | 4 | Director | 02 Jul 2025, 19:41 |
| IKT | Inhibikase Therapeutics, Inc. | 14 Feb 2025 | 2 | $0 | 4 | Director | 19 Feb 2025, 20:19 |
| IKT | Inhibikase Therapeutics, Inc. | 21 Oct 2024 | 2 | +$198,650 | 4 | Director | 23 Oct 2024, 19:49 |
| IKT | Inhibikase Therapeutics, Inc. | 21 Oct 2024 | 0 | $0 | 3 | Director | 23 Oct 2024, 19:40 |
| /report/000141588924005502-kush-arvind-2024-02-26 | RayzeBio, Inc. | 26 Feb 2024 | 4 | -$4,902,062 | 4 | CHIEF FINANCIAL OFFICER | 27 Feb 2024, 16:42 |
| /report/000162828023039538-kush-arvind-2023-11-17 | RayzeBio, Inc. | 17 Nov 2023 | 1 | $0 | 4 | Chief Financial Officer | 17 Nov 2023, 18:38 |
| /report/000120919123049515-kush-arvind-2023-09-14 | RayzeBio, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 14 Sep 2023, 19:39 |